5 Best Upside Stocks To Buy Now

In this piece, we will take a look at the five best upside stocks to buy right now. If you want to find out how recent trends might end up affecting share price upside, then check out the 11 Best Upside Stocks To Buy Now.

5. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Latest Share Price Upside: 64%

Number of Q3 2023 Hedge Fund Investors: 40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a biotechnology company developing treatments for several diseases that cover cancer, nervous system ailments, and sleep disorders. The shares are rated Strong Buy on average and analysts have set an average share price target of $198.92.

By September 2023 end, 40 hedge funds among the 910 tracked by Insider Monkey were Jazz Pharmaceuticals plc (NASDAQ:JAZZ)’s shareholders. Robert Pohly’s Samlyn Capital owned the largest stake among these which was worth $175 million.

Follow Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)

4. Lantheus Holdings, Inc. (NASDAQ:LNTH)

Latest Share Price Upside: 67%

Number of Q3 2023 Hedge Fund Investors: 44

Lantheus Holdings, Inc. (NASDAQ:LNTH) is a specialized medicine company whose products help healthcare workers to diagnose and detect diseases through imaging machines. The firm posted a strong set of financial results in November 2023, that saw its third quarter revenue and net income jump by 33.7% and 100%.

Insider Monkey scoured through 910 hedge fund holdings for their third quarter of 2023 shareholdings and found that 44 had bought the firm’s shares. Lantheus Holdings, Inc. (NASDAQ:LNTH)’s biggest hedge fund investor is Thomas Steyer’s Farallon Capital since it owns 1.5 million shares that are worth $111 million.

Follow Lantheus Holdings Inc. (NASDAQ:LNTH)

3. First Solar, Inc. (NASDAQ:FSLR)

Latest Share Price Upside: 50%

Number of Q3 2023 Hedge Fund Investors: 49

First Solar, Inc. (NASDAQ:FSLR) is a solar panel manufacturer headquartered in Tempe, Arizona. Like other solar power companies, its shares have been facing downward pressures recently as high rates take a bit out of large spending. Naturally, this also leaves First Solar, Inc. (NASDAQ:FSLR) with a sizeable share price upside.

During Q3 2023, 49 out of the 910 hedge funds surveyed by Insider Monkey were First Solar, Inc. (NASDAQ:FSLR) shareholders. Robert Pohly’s Samlyn Capital was the largest shareholder since it owns $293 million worth of shares.

Follow First Solar Inc. (NASDAQ:FSLR)

2. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Latest Share Price Upside: 69%

Number of Q3 2023 Hedge Fund Investors: 50

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology company developing treatments for rare and genetic disorders. The firm’s share price gained double digit percentage points in November after the Food and Drug Administration (FDA) cleared a drug to start trials for muscle disorders.

Insider Monkey scoured through 910 hedge funds for their September quarter of 2023 shareholdings to find that 50 had invested in the company. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s biggest hedge fund shareholder is Kurt Von Emster’s VenBio Select Advisor due to its $487 million investment.

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)

1. Alibaba Group Holding Limited (NYSE:BABA)

Latest Share Price Upside: 63%

Number of Q3 2023 Hedge Fund Investors: 110

Alibaba Group Holding Limited (NYSE:BABA) is a Chinese technology conglomerate with sizeable electronic commerce, cloud computing, and other business divisions. The shares are rated Strong Buy on average and analysts have set an average share price target of $128.05.

As of Q3 2023 end, 110 among the 910 hedge funds tracked by Insider Monkey had bought Alibaba Group Holding Limited (NYSE:BABA)’s shares. Ken Fisher’s Fisher Asset Management was the largest shareholder out of these as it owned a $334 million stake.

Follow Alibaba Group Holding Limited (NYSE:BABA)

Disclosure: None. You can also take a look at Billionaire Paul Tudor Jones and Insiders Love These 11 Stocks and 14 Best Short-Term Stocks to Invest In.

Follow Insider Monkey on Twitter